Absence of MHC class II gene expression in a patient with a single amino acid substitution in the class II transactivator protein CIITA

Immunogenetics

Volumn 49, Issue 11-12, 1999, Pages 957-963

  Quan, Virginia ^a   Towey, Michael ^a,b   Sacks, Steven ^a   Kelly, Adrian P ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Bare lymphocyte syndrome; CIITA; Class II; MHC; Transcription

Indexed keywords

HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PHENYLALANINE; SERINE; TRANSACTIVATOR PROTEIN;

ADULT; AMINO ACID SUBSTITUTION; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL INFECTION; BARE LYMPHOCYTE SYNDROME; CARBOXY TERMINAL SEQUENCE; CASE REPORT; DOWN REGULATION; FLUORESCENCE ACTIVATED CELL SORTER; GENETIC DISORDER; GENETIC TRANSCRIPTION; HELA CELL; HETEROKARYON; HISTOCOMPATIBILITY GENE; HUMAN; HUMAN CELL; MALE; NORTHERN BLOTTING; PRIORITY JOURNAL;

ADULT; AMINO ACID SUBSTITUTION; BACTERIAL INFECTIONS; CELL LINE, TRANSFORMED; FATAL OUTCOME; GENE EXPRESSION REGULATION; GENES, MHC CLASS II; GENETIC COMPLEMENTATION TEST; GENETIC PREDISPOSITION TO DISEASE; HLA-D ANTIGENS; HUMANS; MALE; NUCLEAR PROTEINS; POINT MUTATION; RECURRENCE; SEVERE COMBINED IMMUNODEFICIENCY; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 0032833448     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002510050579     Document Type: Article

References (32)

1. Acolla RS (1983) Human B cell variants immunoselected against a single Ia antigen subset have lost expression in several Ia antigen subsets. J Exp Med 157:1053-1058
2. Bontron S, Steimle V, Ucla C, Eibl MM, Mach B (1997) Two novel mutations in the MHC class II transactivator CIITA is a second patient from MHC class II deficiency complementation group A. Hum Genet 99:541-546
3. Boss JM (1997) Regulation of transcription of MHC class II genes. Curr Opin Immunol 9:107-113
4. Ceman S, Petersen JW, Pinet V, DeMars R (1994) Gene required for normal MHC class II expression and function is localised to approximately 45 kb of DNA in the class II region of the MHC. J Immunol 152:2865-2873
5. Chang C-H, Fontes JD, Peterlin M, Flavell RA (1994) Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatobility complex class II genes. J Exp Med 180:1367-1374
6. Chang C-H, Flavell RA (1995a) Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J Exp Med 181:765-767
7. Chang C-H, Hong S-C, Hughes CCW, Janeway CA, Flavell RA (1995b) CIITA activates the expression of MHC class II genes in mouse T cells. Int Immunol 7:1515-1518
8. Chang C-H, Guerder S, Hong S-C, van Ewijk W, Flavell RA (1996) Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 4:167-178
9. Copier J, Kleijmeer MJ, Ponnambalam S, Oorschot V, Potter P, Trowsdale JT, Kelly A (1996) Targeting signal and subcellular compartments involved in the intracellular trafficking of HLA-DMB. J Immunol 157:1017-1027
10. Douhan III J, Lieberson R, Knoll JHM, Zhou H, Glimcher LH (1997) An isotype-specific activator of major histocompatibility complex (MHC) class II genes that is independent of class II transactivator. J Exp Med 185:1885-1895
11. Douhan III J, Hauber I, Eibl MM, Glimcher L (1996) Genetic evidence for a new type of major histocompatibilty complex class II combined immunodeficiency characterized by a dyscoordinate regulation of HLA-D alpha and beta chains. J Exp Med 183:1063-1069
12. Durand B, Sperisen P, Emery P, Barras E, Zufferey M, Mach B, Reith W (1997) RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency. EMBO J 16:1045-1055
13. Hume CR, Lee JS (1989) Congenital immunodeficiencies associated with absence of HLA class II antigens on lymphocytes result from distinct mutations in trans-acting factors. Hum Immunol 26:288-309
14. Kelly A, Powis SH, Kerr LA, Mockridge I, Elliott T, Bastin J, Uchanska-Ziegler B, Ziegler, A, Trowsdale, J, Townsend A (1992) Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex. Nature 355:641-644
15. Kelly A, Trowsdale J (1995) Complete nucleotide sequence of a functional HLA-DP beta gene and the region between the DP beta 1 and DP alpha 1 genes: comparison of the 5' ends of HLA class II genes. Nucleic Acids Res 13:1607-1621
16. Klein C, Lisowska-Grospierre B, LeDeist F, Fischer A, Griscelli C (1993) Major Histocompatibility complex class II deficiency: clinical manifestations, immunologic features, and outcome. J Pediatr 123:921-928
17. Louis-Plence P, Moreno CS, Boss JM (1997) Formation of a regulatory factor X X2 box-binding protein/nuclear factor-Y multiprotein complex on the conserved regulatory regions of the HLA class II genes. J Immunol 159:3899-3909
18. Mach B, Steimle V, Martinez-Soria E, Reith W (1996) Regulation of MHC class II genes: Lessons from a disease. Annu Rev Immunol 14:301-331
19. Mach B, Steimle V, Reith W (1994) MHC class II-deficient combined immunodeficiency, a disease of gene regulation. Immunol Rev 138:207-221
20. Masternak K, Barras E, Zufferey M, Conrad B, Corthals G, Aebersold R, Sanchez JC, Hochstrasser DF, Mach B, Reith W (1998) A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients. Nat Genet 20:273-277
21. Otten LA, Steimle V, Bontron S, Mach B (1998) Quantitative control of MHC class II expression by the transactivator CIITA. Eur J Immunol 28:473-478
22. Ponnambalam V, Rabouille C, Luzio JP, Nilsson T, Warren G (1994) The TGN38 glycoprotein contains two non-overlapping signals that mediate localization to the trans-Golgi network. J Cell Biol 125:253-268
23. Reith W, Kobr M, Emery P, Durand B, Siegrist CA, Mach B (1994) Cooperative binding between factors RFX and X2 bp to the X and X2 boxes of MHC class II promoters. J Biol Chem 269:20020-20025
24. Reith W, Steimle V, Mach B (1995) Molecular defects in the bare lymphocyte syndrome and regulation of MHC class II genes. Immunol Today 16:539-546
25. Riley JL, Westerheide SD, Price JA, Brown JA, Boss JM (1995) Activation of class II MHC genes requires both the X box region and the Class II Transactivator (CIITA). Immunity 2:533-543
26. Scholl T, Mahanta SK, Strominger JL (1997) Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5. Proc Natl Acad Sci USA 94:6330-6334
27. Shachar I, Flavell RA (1996) Requirement for invariant chain in B cell maturation and function. Science 274:106-108
28. Steimle V, Durand B, Barras E, Zufferey M, Hadam MR, Mach B, Reith W (1995) A novel DNA binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev 9:1021-1032
29. Steimle V, Otten LA, Zufferey M, Mach B (1993) Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75:135-146
30. Steimle V, Siegrist CA, Mottet A, Lisowska-Grospierre B, Mach B (1994) Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science 265:106-109
31. Westerheide SD, Louis-Plence P, Ping D, He XF, Boss JM (1997) HLA-DMA and HLA-DMB gene expression functions through the conserved S-X-Y region. J Immnuol 158:4812-4821
32. Zhou H, Glimcher LH (1995) Human MHC class II gene transcription directed by the carboxy terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity 2:545-553